Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- NMC Health plc AMENDMENT

18 Feb 2020 14:17

RNS Number : 3742D
JPMorgan Securities Plc
18 February 2020
 

AMENDMENT

INCREASED EQUITY PURCHASES BY 166 TO 588,024

INCREASED EQUITY SALES BY 271,221 TO 1,472,065

ADDED EQUITY SWAP PURCHASES OF 165,036

ADDED EQUITY SWAP SALES OF 165,036

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NMC Health plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker & Financial Adviser to NMC Health.

(d) Date dealing undertaken:

12 February 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Share

Purchase

 

Sale

588,024

 

1,472,065

8.7020 GBP

 

8.7172 GBP

7.8060 GBP

 

6.5211 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary Share

Equity Swap

Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short

 

 

 

 

16,450

2,062

3,291

2,903

165,036

21,783

36,588

23,440

224,209

10,639

12,170

4,873

6,381

771

2,155

347

39,781

29,367

32,928

535

1,808

2,720

 

5,176

1,600

21,146

165,036

900

15,006

8.0704 GBP

8.0823 GBP

8.1347 GBP

8.1650 GBP

8.2425 GBP

8.3478 GBP

8.3947 GBP

8.4229 GBP

8.5420 GBP

8.5429 GBP

8.5444 GBP

8.5472 GBP

8.5554 GBP

8.5797 GBP

8.5911 GBP

8.5917 GBP

8.5927 GBP

8.5999 GBP

8.6106 GBP

8.6358 GBP

8.6377 GBP

8.6390 GBP

 

8.1679 GBP

8.3405 GBP

8.4208 GBP

8.5420 GBP

8.5922 GBP

8.6059 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Ordinary Share

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

18 February 2020

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREALAPFFKEEFA
Date   Source Headline
3rd Jan 20147:00 amRNS2013 Full-Year Trading Update
28th Nov 201311:23 amRNSNotification of Transactions
21st Nov 20139:00 amRNSShare Notification
29th Oct 20137:00 amRNSInterim Management Statement
20th Sep 20132:00 pmRNSSale of Shares Announcement
20th Aug 20137:00 amRNSHalf Yearly Results
27th Jun 20134:12 pmRNSAppointment of New Director
27th Jun 20134:11 pmRNSAGM Voting Results
27th Jun 20131:41 pmRNSQ2 Pre Close Statement
4th Jun 20137:00 amRNSJP Morgan Facility Announcement
8th May 20139:21 amRNSShare Notification
30th Apr 20137:00 amRNSInterim Management Statement
4th Apr 201310:04 amRNSTransfer of shares announcement
28th Mar 20134:14 pmRNS2012 ANNUAL REPORT AND ACCOUNTS
19th Mar 201310:31 amRNSShare Notification
15th Mar 20134:38 pmRNSPrice Monitoring Extension
26th Feb 20137:00 amRNSFull Year 2012 preliminary results
3rd Jan 20137:00 amRNSFull year pre-close statement
24th Dec 20127:00 amRNSDirector/PDMR Shareholding
20th Dec 20127:00 amRNSDirector/PDMR Shareholding
26th Nov 201210:30 amRNSNew Hospital Services Management contract
30th Oct 20127:00 amRNSInterim Management Statement
29th Aug 20127:00 amRNSNMC Health plc: Interim Results 2012
2nd Jul 20127:00 amRNSQ2 Pre-close statement
15th May 20127:00 amRNSInterim Management Statement
11th May 201211:00 amRNSNotification of Interim Management Statement
4th May 20124:09 pmRNSDirector/PDMR Shareholding
4th May 20124:09 pmRNSDirector/PDMR Shareholding
4th May 20124:09 pmRNSDirector/PDMR Shareholding
4th May 20124:08 pmRNSDirector/PDMR Shareholding
4th May 20124:07 pmRNSTR-1: Notifications of Major Interests in Shares
4th May 20124:07 pmRNSTR-1: Notifications of Major Interests in Shares
4th May 20124:07 pmRNSTR-1: Notifications of Major Interests in Shares
1st May 20126:29 pmRNSOver-allotment option exercise notice
1st May 20125:30 pmRNSEnd of Stabilisation Notice
13th Apr 20127:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
2nd Apr 20127:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.